Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centex Studies is a private clinical research site organization focused on conducting industry-sponsored clinical trials rather than developing its own therapeutics. The company operated a multi-specialty research site network in Texas and Louisiana, with capabilities spanning patient recruitment, study operations, and physician-partnered trial execution. It became known for its site management model and use of research-enabling technologies such as electronic source documentation, electronic regulatory management, and remote real-time data monitoring. Centex Studies was acquired as part of the initial build-out of Headlands Research, a KKR-backed clinical trial site network, but the Centex Studies name and operating footprint have continued to be referenced in industry and business directories. For a biotech analyst, this is best categorized as a clinical trial site operator/SMO serving sponsors and CROs, not a drug developer with a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centex Studies.